- Ongoing, recruitingTherapeutic exploratory (Phase II)
A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 2 Weeks of Follow-Up to Evaluate Safety and Efficacy of Two Different Dosages of Isocyclosporin A Eye Drop Solution Versus Vehicle in Adult Patients with Atopic Keratoconjunctivitis (AKC).
This study is testing a new eye drop called Isocyclosporin A for adults with a severe allergic eye condition called Atopic Keratoconjunctivitis (AKC). It aims to see if the drops can reduce itchy eyes and are safe to use.
For: Atopic keratoconjunctivitis (AKC)Italy - Ongoing, recruitingTherapeutic exploratory (Phase II)
A 4-Week, Phase II, Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel Group Study With 4 Weeks of Follow-Up to Evaluate Safety and Efficacy of a new formulation of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution at two different Concentrations in patients with Dry Eye Disease (REDUCO study)
This study is testing a new eye drop for dry eye disease. It uses a man-made version of a natural body substance to see if it improves dry eye symptoms and overall eye health over 8 weeks, with a follow-up period.
For: Dry EyeItaly - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective, observer-blind, randomized clinical trial to investigate and compare the clinical efficacy of Chloroprocaine 3% gel and Oxybuprocaine 0.4% eye drops anesthesia for clinical practice in pediatric population.
This study is testing two different eye gels to see which works best at numbing children's eyes before eye exams. We want to find out how well each gel numbs the eye and if they cause any side effects in children aged 0-17.
For: male/female outpatients · aged 0-17 years scheduled to undergo ocular exams with a need of ocular surface anesthesia.Italy